Results

Total Results: 1,397 records

Showing results for "cancer".
Users also searched for: colon cancer screening

  1. www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-statins/statin-use-in-adults-preventive-medication-november-2016
    November 13, 2016 - 95% CI, −0.29% to 0.42%]) (eFigure 11 in the Supplement), 14 , 19 , 22 , 24 , 28 , 29 , 32 , 39 any cancer … , −0.39% to 0.60%]) (eFigure 12 in the Supplement), 14 , 19 , 22 , 23 , 25 , 29-31 , 37 , 39 fatal cancer … were associated with increased risk of withdrawal because of adverse events, serious adverse events, cancer … Statins and the risk of colorectal cancer: a meta-analysis of 18 studies involving more than 1.5 million … Statins and cancer risk: a meta-analysis. JAMA . 2006;295(1):74-80.
  2. www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/cognitive-impairment-in-older-adults-screening
    October 19, 2017 - caregiver education; safety planning; monitored medication use; screening and diagnostic decisions (e.g., cancer
  3. www.uspreventiveservicestaskforce.org/uspstf/recommendation/problem-drinking-screening-1996
    January 01, 1996 - alcohol consumption and elevations in blood pressure and risk of cirrhosis, hemorrhagic stroke, and cancers … larynx, esophagus, and liver. 11-13 A number of studies have reported a modest increase in breast cancer … Alcohol drinking and mortality among men enrolled in an American Cancer Society prospective study. … Alcohol consumption and risk of breast cancer: a review of the epidemiologic evidence.
  4. www.uspreventiveservicestaskforce.org/home/getfilebytoken/aSLgQ3VeNEmowQmpvPk_Xe
    March 01, 2004 - infection leads to improved long-term health outcomes, such as decreased cirrhosis, hepatocellular cancer … mostly international, suggest that patients treated with interferon have lower rates of hepatocellular cancer
  5. www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary1/osteoporosis-screening
    June 26, 2018 - [95% CI, 0.56-1.40]), 117 stroke (0.9% vs 1.2%; RR, 0.69 [95% CI, 0.40-1.18]), 118 or endometrial cancerCancers were reported in 2 groups (3/147 in the placebo group and 3/151 in the 20-μg treatment group) … Continued breast cancer risk reduction in postmenopausal women treated with raloxifene: 4-year results … Breast Cancer Res Treat . 2001;65(2):125-134. 120. Greenspan S, Field-Munves E, Tonino R, et al. … FDA-approved dose] vs placebo): Discontinuations: 9.2% vs 4.8%; RR, 1.94 (95% CI, 0.81-4.69) Cancers
  6. www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary1/osteoporosis-screening-june-2018
    June 26, 2018 - [95% CI, 0.56-1.40]), 117 stroke (0.9% vs 1.2%; RR, 0.69 [95% CI, 0.40-1.18]), 118 or endometrial cancerCancers were reported in 2 groups (3/147 in the placebo group and 3/151 in the 20-μg treatment group) … Continued breast cancer risk reduction in postmenopausal women treated with raloxifene: 4-year results … Breast Cancer Res Treat . 2001;65(2):125-134. 120. Greenspan S, Field-Munves E, Tonino R, et al. … FDA-approved dose] vs placebo): Discontinuations: 9.2% vs 4.8%; RR, 1.94 (95% CI, 0.81-4.69) Cancers
  7. www.uspreventiveservicestaskforce.org/uspstf/recommendation/osteoporosis-screening-2011
    January 15, 2011 - associated with bisphosphonates in case reports, but this condition typically develops in patients with cancer … risk for stroke, and estrogen with progestin increases the risk for coronary heart disease and breast cancer … Systematic review: comparative effectiveness of medications to reduce risk for primary breast cancer.
  8. www.uspreventiveservicestaskforce.org/uspstf/about-uspstf/methods-and-processes/integrating-evidence-based-clinical-and-community-strategies-improve-health
    March 12, 2021 - national efforts to reduce tobacco use 9  and is therefore considered fundamental to evidence-based cancer … The latter has caused an IOM committee addressing strategies to fulfill the potential for cancer early … Fulfilling the potential of cancer prevention and early detection .
  9. www.uspreventiveservicestaskforce.org/uspstf/recommendation/hypertension-in-adults-screening
    April 27, 2021 - of cardiovascular disease in adults Aspirin use to prevent cardiovascular disease and colorectal cancer … cardiovascular disease in adults 16 Aspirin use to prevent cardiovascular disease and colorectal cancer … Aspirin use for the primary prevention of cardiovascular disease and colorectal cancer: US Preventive
  10. www.uspreventiveservicestaskforce.org/home/getfilebytoken/q24h4B37fbrzgPBLHRAgrn
    June 01, 2013 - hepatitis C infection can lead to cirrhosis (scarring) of the liver, end-stage liver disease, and liver cancer
  11. www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-review46/hepatitis-b-virus-infection-screening-2004
    February 15, 2004 - Chang et al., 5 in a retrospective population study using a national cancer registry, showed that the
  12. www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/tfmethods.pdf
    January 01, 2020 - and actual causes of death, United Sta eading cause of death Rate/10 eart disease 258.2 alignant neoplasm … and national efforts to reduce obacco use,9 and is therefore considered fundamental o evidence-based cancer … The latter has caused n IOM committee addressing strategies to fulfill the otential for cancer early … Fulfilling the potential of cancer prevention and early detection.
  13. www.uspreventiveservicestaskforce.org/uspstf/draft-recommendation/hypertension-in-adults-screening
    June 23, 2020 - cardiovascular disease in adults 15 Aspirin use to prevent cardiovascular disease and colorectal cancer … Aspirin use for the primary prevention of cardiovascular disease and colorectal cancer: US Preventive
  14. www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/statin-use-in-adults-preventive-medication
    August 23, 2022 - 1.01]; I 2 = 0%; ARD, 0.09% [95% CI, −0.67% to 0.49%]) (eFigure 10 in the  JAMA  Supplement), any cancer … 71,733; RR, 0.98 [95% CI, 0.91 to 1.04]; I 2 = 0%; ARD, −0.10% [95% CI, −0.38% to 0.18%]), fatal cancer … were associated with increased risk of withdrawal because of adverse events, serious adverse events, cancer … Statins and cancer risk: a meta-analysis. JAMA . 2006;295(1):74-80. doi:10.1001/jama.295.1.74 56. … Statins and the risk of colorectal cancer: a meta-analysis of 18 studies involving more than 1.5 million
  15. www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary50/impaired-visual-acuity-in-older-adults-screening1
    July 15, 2009 - in smokers (β-carotene 83 , 84 ) when prescribed for prevention of cancer or cardiovascular disease. … Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. … [PMID: 8602180] The effect of vitamin E and beta carotene on the incidence of lung cancer and other … cancers in male smokers. … The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. N Engl J Med 1994;330:1029-35.
  16. www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary50/impaired-visual-acuity-in-older-adults-screening-2009
    July 15, 2009 - in smokers (β-carotene 83 , 84 ) when prescribed for prevention of cancer or cardiovascular disease. … Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. … [PMID: 8602180] The effect of vitamin E and beta carotene on the incidence of lung cancer and other … cancers in male smokers. … The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. N Engl J Med 1994;330:1029-35.
  17. www.uspreventiveservicestaskforce.org/home/getfilebytoken/3XUeA-_n8KhYeS95ohoo2_
    August 03, 2020 - effects of iron have been men¬ tioned in the literature, such as claims that it causes birth defects, cancer … Epidemiological evi- dence ofan association between body and iron stores and risk of cancer. … Int J Cancer. 1988;41:677-682. 74. Stevens RG, Jones DY, Micozze MS, Taylor PR. … Body iron stores and the risk of cancer. N Engl J Med. 1988;319:1047-1052. 75.
  18. www.uspreventiveservicestaskforce.org/home/getfilebytoken/We5A-uCMvX5qYeFukGgqks
    March 01, 2004 - outcomes were found up to 5 years after randomization to interferon-beta or placebo (hepatocellular cancer … active (P<0.001); adjusted RR cirrhosis; 0.135 [95% CI, incidence of 0.049–0.372]) hepatocellular cancer … virologic response and sustained biologic response) had a moderately decreased risk for hepatocellular cancer … respond.33,120,141 However, these studies did not consistently find a decreased risk for hepatocellular cancer … outcomes that we evaluated were mortality, end-stage liver disease, cirrhosis, and hepatocellular cancer
  19. www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/hepatitis-c-virus-infection-screening-2004
    March 08, 2004 - outcomes were found up to 5 years after randomization to interferon-beta or placebo (hepatocellular cancer … virologic response and sustained biologic response) had a moderately decreased risk for hepatocellular cancer … 33 , 120 , 141 However, these studies did not consistently find a decreased risk for hepatocellular cancer … estimate benefits of treatment for long-term clinical outcomes such as death, cirrhosis, hepatocellular cancer … Required elevated ALT and liver biopsy consistent with active cirrhosis; incidence of hepatocellular cancer
  20. www.uspreventiveservicestaskforce.org/uspstf/document/draft-research-plan/type2-diabetes-children-adolescents-screening
    July 30, 2020 - from treatment, including gastrointestinal side effects, mortality, myocardial infarction, stroke, cancer

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: